Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.29 +0.73%
Revenue Growth %: +6.1%
Financial Fact:
Other, net: -64K
Today's EPS Names:
SICP, OMID, ELME, More
Revenue Growth %: +6.1%
Financial Fact:
Other, net: -64K
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.06, versus $0.08 reported last year. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.1 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 1st Source (SRCE) PT Raised to $92 at KBW After a 'High Quality Result'
- Booz Allen Hamilton rises on TD Cowen upgrade to buy
- Customers Bancorp (CUBI) PT Raised to $97 at TD Cowen
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
